\
Program Type
Disease
Project Status

Displaying 1 - 25 of 103

Join the VQN
Funded by Award No. OT2OD039875 from NIH...
Precision Dosimetry Imaging Biomarker (PDIB)
FNIH Raises Private Funds to Expand Impact of NIH
Reducing Taxpayer Burden | Accelerating New Treatments | Keeping U.S. at the Forefront Who We Are Passionate scientists and innovators...
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity (REAL BODY)
This project will evaluate inexpensive, accessible, and scalable body composition tools, such as bioelectrical impedance analysis (BIA), 3-d...
Stephen E. Straus Distinguished Lecture
TRUST: Gene and Protein Expression Biomarkers for Frequent Gout Flaring
This project’s objective is to build a predictive multi-omics model for gout flares....
RECOVER-TLC Will Advance Long COVID Research
RECOVER-TLC unites the scientific and patient community in finding new approaches to address Long COVID. This FNIH program is led by NIAID....
The Kovler Prize for Trust in Life Science Journalism
The Kovler Prize for Trust in Life Science Journalism The FNIH is now accepting nominations for the Kovler Prize for Trust in Life Science...
AMP Parkinson’s Disease and Related Disorders
AMP Parkinson’s Disease and Related Disorders (AMP PDRD) builds on the infrastructure established during AMP Parkinson’s Disease (AMP PD...
Joint FDA/FNIH Workshop for Digital Measures
FNIH conducted a joint FDA/FNIH workshop for Digital Measures that brought together industry leaders, regulatory bodies, researchers, and pa...
AMP Amyotrophic Lateral Sclerosis
The Accelerating Medicines Partnership® (AMP®) Amyotrophic Lateral Sclerosis (AMP ALS) is accelerating therapeutic and biomarker developme...
Team Science Day 2024
MMyeRisk: Defining Tumor and Immune Markers to Stratify Patients at Risk of Developing Multiple Myeloma from MGUS and Smoldering Myeloma
AMP Symposium
February 5-6, 2024 – North Bethesda, MD The Accelerating Medicines Partnership® (AMP®) Program was launched in February 2014 to bring t...
Cognitive Aging Summit IV
Biomarkers Consortium – Biomarkers for Risk Stratification and Detection of Early-Onset Preeclampsia
iRelate: Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer
Convening Experts in Oncology to Address Children’s Health (COACH)
Targeted Gene Delivery for Sickle Cell Disease
Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE)
Biomarkers Consortium – Clinical Evaluation and Qualification of Translational Kidney Safety Biomarkers
The ACTIV Tracking Resistance and Coronavirus Evolution (TRACE) Working Group
The Problem Mutations in SARS-CoV-2 are occurring, and some that are reaching high frequency could reduce therapeutic or vaccine efficacy. ...
The Biomedical Research Community Responds to the Opioids Crisis
Overview Opioid addiction, misuse and overdose is an ongoing and rapidly evolving public health crisis. According to the Centers for Diseas...
The Charles A. Sanders Legacy Fund: Honoring Decades of Inspired Leadership, Supporting Novel, Transformative Science
  Honoring Decades of Inspired Leadership The Charles A. Sanders Legacy Fund was established by the Foundation for the Nation...
The Dr. Franklin A. Neva Memorial Fund
Caryn Bern, MD, spoke at this year's Franklin A. Neva Memorial Lecture. Her talk covered the epidemiologist’s perspective on visceral leis...

Diseases

Partner With Us